International Journal of Colorectal Disease

, Volume 25, Issue 8, pp 1017–1020 | Cite as

Transcutaneous electrical posterior tibial nerve stimulation for faecal incontinence: effects on symptoms and quality of life

  • Vitton Veronique
  • Damon Henri
  • Roman Sabine
  • Mion François
Original Article
First Online:
Accepted:

Abstract

Purpose

Faecal incontinence is a disabling symptom which may be particularly difficult to treat. Recent studies showed that transcutaneous electrical posterior tibial nerve stimulation may improve faecal continence. In this study, we aimed to evaluate the effectiveness of this technique and tried to individualize predictive factors of success.

Methods

Twenty-four patients suffering from faecal incontinence were treated 20 min per day by applying transcutaneous electrical posterior tibial nerve stimulation for 3 months. A clinical evaluation was performed at the end of treatment, with Wexner’s score and analogical scales for symptoms. After 3 months, if the treatment was successful, patients were proposed to continue on the treatment. Predictive factors such as age, symptom duration, proctologic history, obstetrical history, ano-rectal manometric data and quality-of-life score were also analysed.

Results

At 3 months, 13 patients (54%) reported a significant symptomatic improvement with a significant modification in the Wexner’s score (14 vs 12, p < 0.025). At a median follow-up of 15 months, there were still 11 patients whose condition was improved.

Conclusion

This study shows encouraging mid-term results, and even if further randomized studies are necessary, transcutaneous electrical posterior tibial nerve stimulation may be a new and easy-to-use therapeutic option to treat faecal incontinence.

Keywords

Faecal incontinence Transcutaneous posterior tibial nerve stimulation Predictive factor of success 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Ganio E, Luc AR, Clerico G, Trompetto M (2001) Sacral nerve stimulation for treatment of fecal incontinence: a novel approach for intractable fecal incontinence. Dis Colon Rectum 44:619–631CrossRefPubMedGoogle Scholar
  2. 2.
    Leroi AM, Parc Y, Lehur PA et al (2005) Efficacy of sacral nerve stimulation for fecal incontinence. Results of a multicenter double-blind crossover study. Ann Surg 242:662–669CrossRefPubMedGoogle Scholar
  3. 3.
    Faucheron JL, Bost R, Duffournet V, Dupuy S, Cardin N, Bonaz B (2006) Sacral neuromodulation in the treatment of severe anal incontinence. Forty consecutive cases treated in one institution. Gastroenterol Clin Biol 30:669–672CrossRefPubMedGoogle Scholar
  4. 4.
    Muñoz-Duyos A, Navarro-Luna A, Brosa M, Pando JA, Sitges-Serra A, Marco-Molina C (2008) Clinical and cost effectiveness of sacral nerve stimulation for faecal incontinence. Br J Surg 95:1037–43CrossRefPubMedGoogle Scholar
  5. 5.
    Vitton V, Abysique A, Gaige S, Leroi AM, Bouvier M (2008) Colonosphincteric electromyographic response to sacral root stimulation: evidence for a somatosympathetic reflex. Neurogastroenterol Motil 20:407–416CrossRefPubMedGoogle Scholar
  6. 6.
    Queralto M, Portier G, Cabarrot PH, Bonnaud G, Chotard JP, Nadrigny M, Lazorthes F (2006) Preliminary results of peripheral transcutaneous neuromodulation in the treatment of idiopathic fecal incontinence. Int J Colorectal Dis 21:670–672CrossRefPubMedGoogle Scholar
  7. 7.
    Vitton V, Damon H, Roman S, Nancey S, Flourie B, Mion F (2009) Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option? Inflamm Bowel Dis 15:402–405CrossRefPubMedGoogle Scholar
  8. 8.
    Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97CrossRefPubMedGoogle Scholar
  9. 9.
    Slim K, Bousquet J, Kwiatkowski F, Lescure G, Pezet D, Chipponi J (1999) First validation of the french version of the Gastrointestinal Quality of Life Index (GIQLI). Gastroenterol Clin Biol 23:25–31PubMedGoogle Scholar
  10. 10.
    Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82:216–222CrossRefPubMedGoogle Scholar
  11. 11.
    Eléouet M, Siproudhis L, Guillou N, Le Couedic J, Damon H, Bretagne JF (2008) Neurostimulation tibiale postérieure dans le traitement de l’incontinence anale sévère. Gastroenterol Clin Biol 32:A135Google Scholar
  12. 12.
    Van der Pal F, Van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL (2006) Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int 97:547–550CrossRefPubMedGoogle Scholar
  13. 13.
    Van Balken MR, Vergunst H, Bemelmans BLH (2006) Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol 49:360–365CrossRefPubMedGoogle Scholar
  14. 14.
    Musial F, Klosterhalfen S, Enck P (2007) Placebo responses. World J Gastroenterol 13:3425–3429PubMedGoogle Scholar
  15. 15.
    Beecher HK (1955) The powerful placebo. J Am Med Assoc 159:1602–1606PubMedGoogle Scholar
  16. 16.
    Thorsteinsson G, Stonnington HH, Stillwell GK et al (1978) The placebo effect of transcutaneous electrical stimulation. Pain 5:31–41CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Vitton Veronique
    • 1
    • 3
  • Damon Henri
    • 1
  • Roman Sabine
    • 1
    • 2
  • Mion François
    • 1
    • 2
  1. 1.Hospices Civils de Lyon, Physiologie digestiveHôpital Edouard HerriotLyonFrance
  2. 2.Université Lyon 1LyonFrance
  3. 3.Hôpital NORDMarseilleFrance

Personalised recommendations